Detection and Quantification of BCR-ABL1 Fusion Transcripts by Droplet Digital PCR

Monitoring BCR-ABL1 fusion transcripts by real-time quantitative RT-PCR has become an important clinical test for the management of patients with chronic myeloid leukemia. However, it has some inherent limitations with regard to its lower limit of detection and limit of quantification. Improvement i...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of molecular diagnostics : JMD Vol. 16; no. 2; pp. 174 - 179
Main Authors Jennings, Lawrence J, George, David, Czech, Juliann, Yu, Min, Joseph, Loren
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Monitoring BCR-ABL1 fusion transcripts by real-time quantitative RT-PCR has become an important clinical test for the management of patients with chronic myeloid leukemia. However, it has some inherent limitations with regard to its lower limit of detection and limit of quantification. Improvement in the lower limit of detection could aid clinicians in selecting candidates for discontinuation of tyrosine kinase inhibitors without relapse. Improvement in the limit of quantification may also avoid unnecessary testing or changes in therapy. Here, we demonstrate the advantages of droplet digital RT-PCR with regard to simplicity, lower limit of detection, and limit of quantification. We expect the advantages of droplet digital RT-PCR will make it the preferred method for quantification of BCR-ABL1 fusion transcripts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1525-1578
1943-7811
DOI:10.1016/j.jmoldx.2013.10.007